Lethal Factor of Bacillus anthracis (FDA)
lgG to Trypanosoma cruzi (FDA/CE)
POC Antigen (FDA 510(k))
NS1 Antigen (CE)
Cutaneous Leishmaniasis in skin lesions (FDA/CE)
Visceral Leishmaniasis (FDA/CE)
CPS to Burkholderia pseudomallei (In Development)
IgG to O. tsutsugamushi (RUO)
IgM to O. tsutsugamushi (RUO)